查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1401846

到 2030 年的神經技術市場預測：按產品、病理狀況、最終用戶和地區進行的全球分析

Neurotechnology Market Forecasts to 2030 - Global Analysis By Product, Condition, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2023 年全球神經技術市場規模為 145.5 億美元，預計到 2030 年將達到 353.1 億美元，預測期內複合年成長率為 13.5%。

神經技術是指利用工程學、電子學、電腦科學和其他學科來理解、修復、替換、增強或影響神經系統的功能。這個跨學科領域涵蓋了與大腦和神經系統相互作用的廣泛技術和應用。它有望了解大腦並開發醫療保健、通訊和人類增強方面的創新應用。

根據聯合國估計，全球每年約有 10 億人受到神經病變的影響。

神經系統疾病盛行率增加

阿茲海默症、帕金森氏症、癲癇和各種形式的神經病變疼痛等神經系統疾病在世界各地變得越來越普遍。人口高齡化、生活方式的改變和環境因素導致這些疾病的發生率上升。總體而言，神經系統疾病的日益普及正在創造對先進有效解決方案的需求，推動神經技術市場的創新和成長。

道德和隱私問題

神經技術通常涉及高度個人化和敏感的大腦資料的收集和分析。確定誰擁有和控制神經技術設備產生的資料是一項道德和法律挑戰。解決此類道德和隱私問題對於獲得公眾信任、確保負責任的發展以及確保神經技術創新的廣泛接受至關重要。

神經科學研究進展

神經科學的進步有助於識別和理解與各種神經系統疾病相關的生物標記。神經科學的持續研究有助於更深入地了解大腦功能。神經科學研究和神經技術發展之間的共生關係是理解、診斷和治療各種神經系統疾病的創新解決方案不斷發展的驅動力。隨著神經科學不斷揭開大腦的奧秘，它為具有多種應用的神經技術的進步提供了豐富的基礎。

開發成本高

神經技術通常整合多個領域的專業知識，例如電腦科學、工程和神經病學。開發神經技術解決方案以確保安全性、有效性和法規遵循需要透過臨床試驗進行徹底的測試。這種資源集中研究會顯著增加總開發成本。此外，與智慧財產權、長期測試和檢驗以及針對個別變化的客製化相關的費用增加了總成本並阻礙了市場開拓。

COVID-19 的影響

與許多其他領域一樣，神經技術領域的研發活動因疫情造成的干擾而出現了延誤。實驗室和研究設施面臨關閉和能力限制，影響了創新的步伐。這次疫情也引起了人們對心理健康問題的關注，提高了人們對監測和解決心理健康問題重要性的認知。此外，疫情增加了政府和私人投資者對醫療保健技術融資的興趣，吸引了更多資本進入該行業。

神經復健領域預計在預測期內規模最大

神經復健領域預計將出現良好的成長。神經復健是一個專門的復健領域，專注於神經病變和損傷患者的恢復和改善。神經復健旨在提高運動技能、平衡、協調和精細運動技能等功能能力。其他好處，包括心理健康、生活品質提高、長期獨立和疼痛管理，正在推動這一領域的發展。

認知障礙產業預計在預測期內複合年成長率最高

認知障礙產業預計在預測期內複合年成長率最高。神經技術工具提供認知障礙的客觀生物標記。腦影像技術等神經技術工具可以幫助早期發現和診斷認知障礙。這種方法可以幫助個人學習大腦功能的自我調節並提高認知能力。此外，個人化治療計劃、增強的神經可塑性、治療效果監測和生活品質改善等因素也為該細分市場提供了有利的成長。

佔有率最大的地區

預計亞太地區在預測期內將佔據最大的市場佔有率。亞太地區對醫療保健技術的興趣和投資正在增加。許多主要企業都位於該地區，包括 NeuroSky、NeuroLifeSciences、NeuClonec、Neuro Device Group 和 Neural Analytics。提高對神經技術益處的認知和教育，以及該地區神經病變的上升，進一步支持了該地區的市場擴張。

複合年成長率最高的地區：

預計歐洲在預測期內的複合年成長率最高。新興國家積極致力於神經技術領域的研發。歐洲的神經技術領域正在吸引新創公司和老牌新興企業的投資和資助。此外，在歐洲，神經技術的研究和應用強調倫理考量。該地區不斷增加的投資和研究合作正在促進神經技術市場的成長。

免費客製化服務：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球神經技術市場：依產品

  • 神經感應
  • 神經假體
  • 神經復健
  • 神經刺激
    • 薦骨神經刺激器
    • 迷走神經刺激設備
    • 胃電刺激設備
    • 脊髓刺激設備
    • 深部腦部刺激器
    • 經皮神經電刺激 (TENS)
  • 其他產品

第6章全球神經科技市場：依病理

  • 疼痛治療
  • 尿失禁和大便失禁
  • 認知障礙
  • 帕金森氏症
  • 憂鬱症
  • 癲癇
  • 睡眠失調
  • 聽力狀況
  • 自發性震顫
  • 其他條件

第7章 全球神經科技市場：依最終用戶分類

  • 醫院
  • 居家照護設施
  • 門診手術中心
  • 其他最終用戶

第8章全球神經技術市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第9章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第10章 公司簡介

  • General Electric
  • Hitachi Medical
  • Siemens Healthcare
  • Elekta
  • Koninklijke Philips
  • Canon Medical Systems
  • Magstim
  • Allengers Medical
  • Abbott Laboratories
  • Neuralink Corporation
  • Boston Scientific Corporation
  • Advanced Bionics AG（Sonova）
  • Tristan Technologies
  • Shimadzu
  • Medtronic PLC
  • Blackrock Microsystems
  • NeuroVigil Inc.
  • Integra LifeSciences
  • Natus medical Incorporated
  • Nihon Kohden Corporation
Product Code: SMRC24366

According to Stratistics MRC, the Global Neurotechnology Market is accounted for $14.55 billion in 2023 and is expected to reach $35.31 billion by 2030 growing at a CAGR of 13.5% during the forecast period. Neurotechnology refers to the use of engineering, electronics, computer science, and other disciplines to understand, repair, replace, enhance, or otherwise influence the functioning of the nervous system. This multidisciplinary field encompasses a wide range of technologies and applications that interact with the brain and the nervous system. It holds promise for both understanding the brain and developing innovative applications for healthcare, communication, and human augmentation.

According to the United Nations estimates, around 1 billion individuals worldwide are affected by neurological disorders every year.

Market Dynamics:

Driver:

Increasing prevalence of neurological disorders

Neurological disorders, such as Alzheimer's disease, Parkinson's disease, epilepsy, and various forms of neuropathic pain, are becoming more prevalent globally. The aging population, lifestyle changes, and environmental factors contribute to the increasing incidence of these disorders. Overall, the increasing prevalence of neurological disorders creates a demand for advanced and effective solutions, driving innovation and growth in the neurotechnology market.

Restraint:

Ethical and privacy concerns

Neurotechnology often involves the collection and analysis of highly personal and sensitive brain data. Determining who owns and controls the data generated by neurotechnological devices is an ethical and legal challenge. Addressing these ethical and privacy concerns is critical for gaining public trust, ensuring responsible development, and fostering widespread acceptance of neurotechnological innovations.

Opportunity:

Advancements in neuroscience research

Advances in neuroscience help identify and understand biomarkers associated with different neurological conditions. Ongoing research in neuroscience contributes to a deeper understanding of brain function. The symbiotic relationship between neuroscience research and neurotechnology development is a driving force behind the continuous evolution of innovative solutions for understanding, diagnosing, and treating various neurological conditions. As neuroscience continues to uncover the mysteries of the brain, it provides a rich foundation for the advancement of neurotechnologies with diverse applications.

Threat:

High development costs

Integration of expertise from several fields, including computer science, engineering, and neurology, is common in neurotechnology. Thorough testing through clinical trials is necessary for developing neurotechnological solutions to guarantee safety, effectiveness, and regulatory compliance. These resource-intensive studies have the potential to greatly increase total development costs. Furthermore, expenditures associated with intellectual property, lengthy testing and validation, and customisation for individual variations enhances total costs and impedes market development.

COVID-19 Impact

The neurotechnology sector, like many others, have experienced delays in research and development activities due to disruptions caused by the pandemic. Laboratories and research facilities faced closures or limitations in capacity, affecting the pace of innovation. Also, the pandemic has brought attention to mental health issues, and there is a growing awareness of the importance of monitoring and addressing mental well-being. Additionally, governments and private investors have shown an increased interest in funding healthcare technologies due to the pandemic which have attracted additional funding in the sector.

The neurorehabilitation segment is expected to be the largest during the forecast period

The neurorehabilitation segment is estimated to have a lucrative growth. Neurorehabilitation is a specialized field of rehabilitation focused on the recovery and improvement of individuals with neurological disorders or injuries. Neurorehabilitation aims to enhance functional abilities such as mobility, balance, coordination, and fine motor skills. Additionally, its benefits such as psychological well-being, improved quality of life, long-term independence and pain management boost the segment growth.

The cognitive disorders segment is expected to have the highest CAGR during the forecast period

The cognitive disorders segment is anticipated to witness the highest CAGR growth during the forecast period. Neurotechnological tools provide objective biomarkers for cognitive disorders. Neurotechnology tools, such as brain imaging techniques, can help in early detection and diagnosis of cognitive disorders. This approach helps individuals learn to self-regulate their brain function and improve cognitive performance. Also, its elements such as personalized treatment plans, enhancing neuroplasticity, monitoring treatment efficacy and quality of life improvements provides lucrative growth to the segment.

Region with largest share:

Asia Pacific is projected to hold the largest market share during the forecast period. The Asia Pacific region has shown increasing interest and investment in healthcare technologies. The region is home for many key players such as NeuroSky, NeuroLifeSciences, NeuClonec, Neuro Device Group and Neural Analytics. The region's increased awareness and education about the benefits of neurotechnology along with rising incidence of neurological disorders is further propelling the market expansion in this region.

Region with highest CAGR:

Europe is projected to have the highest CAGR over the forecast period. European countries are actively involved in research and development in the field of neurotechnology. The neurotechnology sector in Europe has attracted investments and funding for both start-ups and established companies. Also, Europe places a strong emphasis on ethical considerations in neurotechnology research and application. The rising investments and collaborations in the region contribute to the growth of the neurotechnology market.

Key players in the market:

Some of the key players profiled in the Neurotechnology Market include General Electric, Hitachi Medical, Siemens Healthcare, Elekta, Koninklijke Philips, Canon Medical Systems, Magstim, Allengers Medical, Abbott Laboratories, Neuralink Corporation, Boston Scientific Corporation, Advanced Bionics AG (Sonova), Tristan Technologies, Shimadzu, Medtronic PLC, Blackrock Microsystems, NeuroVigil Inc., Integra LifeSciences, Natus medical Incorporated and Nihon Kohden Corporation.

Key Developments:

In October 2023, Canon launched its innovative solution "nanoimprint lithography" system. The system is expected to represent the company's competitive response to ASML, a Dutch firm, a force in the extreme ultraviolet (EUV) lithography machine sector.

In July 2022, GE Healthcare, a global medical technology, diagnostics, and digital solutions innovator, announced the launch of its 5G Innovation Lab in India and across the globe. The lab is designed to position GE Healthcare advances in patient care and to bring cutting-edge technology to rural and sub-urban regions.

In March 2022, Siemens Healthineers introduced its unique solutions in MRI and CT portfolio- MAGNETOM Free.Star and NAEOTOM Alpha®. These latest additions in their portfolio truly reflect their purpose "We pioneer breakthroughs in healthcare For Everyone & Everywhere."

Products Covered:

  • Neurosensing
  • Neuroprostheses
  • Neurorehabilitation
  • Neurostimulation
  • Others Products

Conditions Covered:

  • Pain Treatment
  • Urinary & Fecal Incontinence
  • Cognitive Disorders
  • Parkinson's Disease
  • Depression
  • Epilepsy
  • Sleep Disorder
  • Hearing Conditions
  • Essential Tremor
  • Other Conditions

End Users Covered:

  • Hospitals
  • Homecare Facilities
  • Ambulatory Surgical Centers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Neurotechnology Market, By Product

  • 5.1 Introduction
  • 5.2 Neurosensing
  • 5.3 Neuroprostheses
  • 5.4 Neurorehabilitation
  • 5.5 Neurostimulation
    • 5.5.1 Sacral Nerve Stimulator
    • 5.5.2 Vagus Nerve Stimulator
    • 5.5.3 Gastric Electric Stimulator
    • 5.5.4 Spinal Cord Stimulator
    • 5.5.5 Deep Brain Stimulator
    • 5.5.6 Transcutaneous Electrical Nerve Stimulation (TENS)
  • 5.6 Other Products

6 Global Neurotechnology Market, By Condition

  • 6.1 Introduction
  • 6.2 Pain Treatment
  • 6.3 Urinary & Fecal Incontinence
  • 6.4 Cognitive Disorders
  • 6.5 Parkinson's Disease
  • 6.6 Depression
  • 6.7 Epilepsy
  • 6.8 Sleep Disorder
  • 6.9 Hearing Conditions
  • 6.10 Essential Tremor
  • 6.11 Other Conditions

7 Global Neurotechnology Market, By End User

  • 7.1 Introduction
  • 7.2 Hospitals
  • 7.3 Homecare Facilities
  • 7.4 Ambulatory Surgical Centers
  • 7.5 Other End Users

8 Global Neurotechnology Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 General Electric
  • 10.2 Hitachi Medical
  • 10.3 Siemens Healthcare
  • 10.4 Elekta
  • 10.5 Koninklijke Philips
  • 10.6 Canon Medical Systems
  • 10.7 Magstim
  • 10.8 Allengers Medical
  • 10.9 Abbott Laboratories
  • 10.10 Neuralink Corporation
  • 10.11 Boston Scientific Corporation
  • 10.12 Advanced Bionics AG (Sonova)
  • 10.13 Tristan Technologies
  • 10.14 Shimadzu
  • 10.15 Medtronic PLC
  • 10.16 Blackrock Microsystems
  • 10.17 NeuroVigil Inc.
  • 10.18 Integra LifeSciences
  • 10.19 Natus medical Incorporated
  • 10.20 Nihon Kohden Corporation

List of Tables

  • Table 1 Global Neurotechnology Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Neurotechnology Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Neurotechnology Market Outlook, By Neurosensing (2021-2030) ($MN)
  • Table 4 Global Neurotechnology Market Outlook, By Neuroprostheses (2021-2030) ($MN)
  • Table 5 Global Neurotechnology Market Outlook, By Neurorehabilitation (2021-2030) ($MN)
  • Table 6 Global Neurotechnology Market Outlook, By Neurostimulation (2021-2030) ($MN)
  • Table 7 Global Neurotechnology Market Outlook, By Sacral Nerve Stimulator (2021-2030) ($MN)
  • Table 8 Global Neurotechnology Market Outlook, By Vagus Nerve Stimulator (2021-2030) ($MN)
  • Table 9 Global Neurotechnology Market Outlook, By Gastric Electric Stimulator (2021-2030) ($MN)
  • Table 10 Global Neurotechnology Market Outlook, By Spinal Cord Stimulator (2021-2030) ($MN)
  • Table 11 Global Neurotechnology Market Outlook, By Deep Brain Stimulator (2021-2030) ($MN)
  • Table 12 Global Neurotechnology Market Outlook, By Transcutaneous Electrical Nerve Stimulation (TENS) (2021-2030) ($MN)
  • Table 13 Global Neurotechnology Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 14 Global Neurotechnology Market Outlook, By Condition (2021-2030) ($MN)
  • Table 15 Global Neurotechnology Market Outlook, By Pain Treatment (2021-2030) ($MN)
  • Table 16 Global Neurotechnology Market Outlook, By Urinary & Fecal Incontinence (2021-2030) ($MN)
  • Table 17 Global Neurotechnology Market Outlook, By Cognitive Disorders (2021-2030) ($MN)
  • Table 18 Global Neurotechnology Market Outlook, By Parkinson's Disease (2021-2030) ($MN)
  • Table 19 Global Neurotechnology Market Outlook, By Depression (2021-2030) ($MN)
  • Table 20 Global Neurotechnology Market Outlook, By Epilepsy (2021-2030) ($MN)
  • Table 21 Global Neurotechnology Market Outlook, By Sleep Disorder (2021-2030) ($MN)
  • Table 22 Global Neurotechnology Market Outlook, By Hearing Conditions (2021-2030) ($MN)
  • Table 23 Global Neurotechnology Market Outlook, By Essential Tremor (2021-2030) ($MN)
  • Table 24 Global Neurotechnology Market Outlook, By Other Conditions (2021-2030) ($MN)
  • Table 25 Global Neurotechnology Market Outlook, By End User (2021-2030) ($MN)
  • Table 26 Global Neurotechnology Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 27 Global Neurotechnology Market Outlook, By Homecare Facilities (2021-2030) ($MN)
  • Table 28 Global Neurotechnology Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 29 Global Neurotechnology Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.